Results 141 to 150 of about 19,433 (209)

Phosphaturic Mesenchymal Tumor: From Invisibility to Bedridden Morbidity. [PDF]

J ASEAN Fed Endocr Soc
Mukherjee R, Pattashanee SK, Singh BK, Krishna A, Soren S, Damle AN, Sharma MC, Seenu V.   +7 more
europepmc   +1 more source

Association between serum phosphate levels and outcome among critically ill newborns: a retrospective cohort study. [PDF]

Front Pediatr
Bao L, Liu X, Zhao C, Li J, Li D, Du Z.
europepmc   +1 more source

Burosumab as bridging therapy in autosomal dominant hypophosphatemic rickets with femoral fracture nonunion and iron deficiency. [PDF]

JBMR Plus
Rakusa M, Kocjan T.
europepmc   +1 more source

Bilateral Pathological Femoral Fractures Secondary to Long-Term Tenofovir Disoproxil Fumarate-Induced Osteomalacia in a Woman Living with HIV: A Case Report. [PDF]

Int Med Case Rep J
Jawahar Kanth JS, Okello MO, Anish TMR, Namutebi F, Namawejje P, Segawa MC, Rutakingirwa MK, Mbabazi P, Meya D.   +8 more
europepmc   +1 more source

Hypophosphatemia in kidney stone formers. [PDF]

Curr Opin Nephrol Hypertens
Prochaska M, Zisman A.
europepmc   +1 more source

Editorial: Bone metastases in endocrine cancers: advances in diagnosis, treatment, and prevention. [PDF]

Front Endocrinol (Lausanne)
Mandal CC, Rhoades JA.
europepmc   +1 more source

Determinants of final height in X-linked hypophosphatemia: impact of diagnostic delay and baseline growth in a Brazilian cohort. [PDF]

Front Pediatr
Borghi M, Moreira JPB, da Silva LM.
europepmc   +1 more source

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia. [PDF]

JCEM Case Rep
Alsayed Hasan M, Al Mukaddam M.
europepmc   +1 more source